2026/2027 NR 566 Final Exam With Questions and Answers (Graded A+)
2026/2027 NR 566 Final Exam With Questions and Answers (Graded A+) 1. Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin) 2. Selective Estrogen Receptor Modulators (SERMs) 3. Dysfunctional uterine bleeding 4. Amenorrhea treatment 5. Amenorrhea estrogen levels are low 6. Long term progestin therapy alternatives for hormone replacement therapy Tamoxifen, toremifene, raloxifene -- provide estrogen benefits while avoiding its drawbacks 10-14 day course of progestin progestin helps induce menstrual flow give progestin for 5-10 days protection against endometrial cancer
Written for
- Institution
- NR 566
- Course
- NR 566
Document information
- Uploaded on
- April 1, 2026
- Number of pages
- 10
- Written in
- 2025/2026
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
nr 566 final exam with questions and ans